Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Peptide Immunotherapy Shown Safe for Type 1 Diabetes

In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes

Faster Process Devised for Targeted Antibodies

Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies. . . . → Read More: Faster Process Devised for Targeted Antibodies

Clinical Trial Begins for Liver Dialysis Device

A clinical trial is underway in Europe testing a device that works like dialysis to clear toxins from the blood associated with liver failure, where a transplant is often the only option. . . . → Read More: Clinical Trial Begins for Liver Dialysis Device

Grant Funding Automated Genome Editing System

A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique. . . . → Read More: Grant Funding Automated Genome Editing System

Device Shown to Reduce Migraine Occurrence

A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence. . . . → Read More: Device Shown to Reduce Migraine Occurrence

Game App Improves Memory Among Cognitive Impaired

A brain training game for an iPad was shown in a clinical study to improve the memory of people with mild cognitive impairment, a precursor stage to dementia. . . . → Read More: Game App Improves Memory Among Cognitive Impaired

Glaxo Using Artificial Intelligence for Drug Discovery

Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets. . . . → Read More: Glaxo Using Artificial Intelligence for Drug Discovery

Nerve Stimulation Approved for Children’s Epilepsy

The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old. . . . → Read More: Nerve Stimulation Approved for Children’s Epilepsy

Computer-Designed Antibodies Target Alzheimer’s Proteins

Researchers in Europe designed antibodies, like those in the immune system, to attack protein deposits in the brain associated with Alzheimer’s disease. . . . → Read More: Computer-Designed Antibodies Target Alzheimer’s Proteins

$300M Fund to Back European Life Science Companies

A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies